ICU Medical Inc. (NASDAQ:ICUI) shares were up 2.1% during mid-day trading on Thursday . The company traded as high as $125.56 and last traded at $124.71, with a volume of 59,705 shares trading hands. The stock had previously closed at $122.18.

A number of research firms have weighed in on ICUI. Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $140.00 target price on the stock in a research note on Friday, August 12th. Piper Jaffray Cos. reaffirmed a “neutral” rating and set a $119.00 target price (up previously from $115.00) on shares of ICU Medical in a research note on Thursday, August 11th.

The firm has a 50 day moving average price of $118.30 and a 200-day moving average price of $105.10. The company has a market cap of $2.01 billion and a PE ratio of 37.05.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Monday, August 8th. The company reported $1.15 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.05 by $0.10. The company had revenue of $96.70 million for the quarter, compared to the consensus estimate of $89.66 million. During the same period in the prior year, the company earned $0.97 earnings per share. The firm’s revenue was up 15.4% on a year-over-year basis. Equities analysts expect that ICU Medical Inc. will post $4.54 EPS for the current year.

In other ICU Medical news, insider Kevin J. Mcgrody sold 14,257 shares of the stock in a transaction that occurred on Monday, August 15th. The shares were sold at an average price of $124.11, for a total value of $1,769,436.27. Following the sale, the insider now directly owns 1,922 shares in the company, valued at approximately $238,539.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Joseph R. Saucedo sold 2,000 shares of the stock in a transaction that occurred on Friday, July 29th. The stock was sold at an average price of $115.47, for a total transaction of $230,940.00. Following the completion of the sale, the director now owns 4,348 shares in the company, valued at $502,063.56. The disclosure for this sale can be found here.

An institutional investor recently bought a new position in ICU Medical stock. Airain ltd bought a new stake in ICU Medical Inc. (NASDAQ:ICUI) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 8,950 shares of the company’s stock, valued at approximately $1,009,000. Airain ltd owned about 0.06% of ICU Medical at the end of the most recent quarter.

ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.